NJB-834

N/A

Report date: 2023/02/26 21:49:46
NME

Base Information

Drug NameNJB-834
Drug Alias NameNJB-834
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionToll like receptor 9 agonists
TargetsToll like receptor 9
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNapajen Pharma
China Registration ClassN/A

Develop Information

Active CompaniesNapajen Pharma
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A